Novo Nordisk bids $9bn for weight problems drug maker Metsera in problem to Pfizer | Prescription drugs trade
Novo Nordisk has launched a shock $9bn (£6.9bn) provide for the US obesity-focused biotech agency Metsera that might gazump an ...
Novo Nordisk has launched a shock $9bn (£6.9bn) provide for the US obesity-focused biotech agency Metsera that might gazump an ...
 Copyright © 2025  Greater USA.
 Greater USA is not responsible for the content of external sites.